e-learning
resources
Munich 2014
Tuesday, 09.09.2014
Clinical management of interstitial lung diseases and vasculitis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The role of cardiac magnetic resonance in detection and monitoring of the treatment efficacy of heart involvement in EGPA patients
J. Fijolek, E. Wiatr, D. Gawryluk, U. Nowicka, J. Kober, D. Piotrowska-Kownacka, M. Szolkowska, K. Roszkowski-Sliz (Warsaw, Poland)
Source:
International Congress 2014 – Clinical management of interstitial lung diseases and vasculitis
Session:
Clinical management of interstitial lung diseases and vasculitis
Session type:
Poster Discussion
Number:
4512
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Fijolek, E. Wiatr, D. Gawryluk, U. Nowicka, J. Kober, D. Piotrowska-Kownacka, M. Szolkowska, K. Roszkowski-Sliz (Warsaw, Poland). The role of cardiac magnetic resonance in detection and monitoring of the treatment efficacy of heart involvement in EGPA patients. Eur Respir J 2014; 44: Suppl. 58, 4512
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Related content which might interest you:
The utility of cardiac magnetic resonance imaging in the diagnosis of cardiac sarcoidosis
Source: International Congress 2014 – The MRI modality becomes clinically mature: lung MRI
Year: 2014
Evaluation of T1-mapping magnetic resonance imaging for the detection of chronic lung allograft dysfunction
Source: International Congress 2014 – The MRI modality becomes clinically mature: lung MRI
Year: 2014
Emerging role of cardiovascular magnetic resonance imaging in the management of pulmonary hypertension
Source: Eur Respir Rev, 29 (156) 190138; 10.1183/16000617.0138-2019
Year: 2020
Early alterations of lung parenchyma in acromegaly
Source: International Congress 2014 – Pathophysiological mechanisms at different scales
Year: 2014
Long-term results obtained by cardiovascular magnetic resonance imaging and somatostatin receptor PET in cardiac sarcoidosis
Source: International Congress 2016 – Mixed-up imaging of various chest diseases
Year: 2016
Value of MR imaging in the early detection of cardiac involvement in sarcoidosis
Source: Annual Congress 2006 - New modalities and application in imaging of the chest
Year: 2006
Diagnostic and prognostic value of advanced imaging modalities in patients with suspected cardiac sarcoidosis
Source: International Congress 2016 – Sarcoidosis
Year: 2016
Development of the nasal cavity during infancy: A restrospective CT imaging study
Source: International Congress 2014 – Functional imaging
Year: 2014
Value of proton magnetic resonance spectroscopy of brain to study the cerebral metabolic abnormalities in COPD: Initial experience
Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation
Year: 2013
Cardiac magnetic resonance imaging versus echocardiography for assessment of cardiac involvement in pulmonary sarcoidosis
Source: Annual Congress 2012 - Pulmonary circulation and functional lung imaging
Year: 2012
Paradoxical response to bronchodilators: Radiologic correlates and clinical implications
Source: International Congress 2014 – Modern approach and old dilemmas in lung diseases
Year: 2014
Characterisation of acinar airspace involvement in patients with asthma using hyperpolarised
3
He magnetic resonance and quantitative computed tomography
Source: International Congress 2014 – Functional imaging
Year: 2014
Delayed gas filling imaged in asthma patients using hyperpolarised
3
He MRI
Source: International Congress 2014 – Functional imaging
Year: 2014
Quantitative dynamic contrast-enhanced MRI of the lung in asthma
Source: International Congress 2014 – The MRI modality becomes clinically mature: lung MRI
Year: 2014
Magnetic resonance with diffusion weighted imaging: A new method to detect active lung inflammation in patients with primary antibody deficiencies
Source: International Congress 2014 – Biomarkers of asthma and clinical immunology
Year: 2014
Detecting cardiac involvement in sarcoidosis: a call for prospective studies of newer imaging techniques
Source: Eur Respir J 2007; 29: 418-422
Year: 2007
Cardiac sarcoidosis detected by magnetic resonance imaging – Preliminary report of prospective study
Source: International Congress 2015 – Acute and chronic lung diseases: good clinical practice
Year: 2015
The role of magnetic resonance imaging in staging of NSCLC
Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer
Year: 2013
Visualising regional ventilation heterogeneity by linking multiple breath washout to
3
He MRI imaging
Source: International Congress 2014 – Functional imaging
Year: 2014
Clinical evaluation of RV wall stress in pulmonary arterial hypertension: A follow-up study using magnetic resonance imaging
Source: Annual Congress 2011 - Clinical characteristics of patients with pulmonary hypertension
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept